Equities

Sun Pharma Advanced Research Co Ltd

Sun Pharma Advanced Research Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)218.41
  • Today's Change-0.09 / -0.04%
  • Shares traded306.46k
  • 1 Year change-5.86%
  • Beta1.5692
Data delayed at least 15 minutes, as of Sep 20 2024 11:21 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income(3868)(2226)(2034)
Depreciation/depletion125118102
Non-Cash items(234)(48)65
Cash taxes paid, supplemental41(54)(45)
Cash interest paid, supplemental1677142
Changes in working capital(314)1,465(215)
Total cash from operations(4292)(691)(2082)
INVESTING
Capital expenditures(265)(154)(327)
Other investing and cash flow items, total4,180(5329)35
Total cash from investing3,915(5483)(292)
FINANCING
Financing cash flow items(16)(77)(223)
Total cash dividends paid------
Issuance (retirement) of stock, net--7,0284,093
Issuance (retirement) of debt, net440(783)(1576)
Total cash from financing4246,1682,293
NET CHANGE IN CASH
Foreign exchange effects0.020(0.02)
Net change in cash47(6.41)(81)
Net cash-begin balance/reserved for future use5.841293
Net cash-end balance/reserved for future use535.8412
SUPPLEMENTAL INCOME
Depreciation, supplemental125118102
Cash interest paid, supplemental1677142
Cash taxes paid, supplemental41(54)(45)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.